Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Rigel Pharmaceuticals’s stock clocked out at $1.13, up 4.63% from its previous closing price of $1.08. In other words, the price has increased by $4.63 from its previous closing price. On the day, 3.34 million shares were traded. RIGL stock price reached its highest trading level at $1.14 during the session, while it also had its lowest trading level at $1.06.
Ratios:
To gain a deeper understanding of RIGL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.76 and its Current Ratio is at 1.86.
Piper Sandler Downgraded its Overweight to Neutral on June 08, 2022, whereas the target price for the stock was revised from $7 to $1.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 05 ’24 when RODRIGUEZ RAUL R sold 30,545 shares for $1.14 per share. The transaction valued at 34,821 led to the insider holds 2,036,629 shares of the business.
Santos David A sold 8,918 shares of RIGL for $10,167 on Feb 05 ’24. The EVP, Chief Commercial Officer now owns 349,093 shares after completing the transaction at $1.14 per share. On Feb 05 ’24, another insider, Schorno Dean L, who serves as the EVP & Chief Financial Officer of the company, sold 7,027 shares for $1.14 each. As a result, the insider received 8,011 and left with 402,891 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RIGL now has a Market Capitalization of 198207648 and an Enterprise Value of 236640032. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.70. Its current Enterprise Value per Revenue stands at 2.044 whereas that against EBITDA is -11.627.
Stock Price History:
Over the past 52 weeks, RIGL has reached a high of $1.96, while it has fallen to a 52-week low of $0.71. The 50-Day Moving Average of the stock is -15.05%, while the 200-Day Moving Average is calculated to be -5.04%.
Shares Statistics:
It appears that RIGL traded 1.31M shares on average per day over the past three months and 1917750 shares per day over the past ten days. A total of 174.83M shares are outstanding, with a floating share count of 171.94M. Insiders hold about 1.96% of the company’s shares, while institutions hold 60.97% stake in the company. Shares short for RIGL as of 1711584000 were 5013843 with a Short Ratio of 3.82, compared to 1709164800 on 3738355. Therefore, it implies a Short% of Shares Outstanding of 5013843 and a Short% of Float of 2.9000001.
Earnings Estimates
The current rating of Rigel Pharmaceuticals (RIGL) reflects the combined expertise of Transocean Ltd (Switzerland) analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $1.13, with high estimates of $2.84 and low estimates of $0.11.
